此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Cerebral and Cardiac Blood Flow During Exercise in Patients With COPD (REFLEX-COPD)

2019年10月28日 更新者:University of Nottingham

Cardiac Output and Brain Perfusion and Architecture During Exercise in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Healthy, Age Matched Volunteers

Heart disease and conditions related to the blood vessels are responsible for a large proportion (over a quarter) of the deaths in people with chronic obstructive pulmonary disease (COPD). The changes can also affect the smaller smaller blood vessels within the body, in particular the brain and the kidneys. This might be related to how the heart pumps and if it is under any pressure. Investigations performed at the University in healthy older volunteers demonstrated how the blood flows in the brain and heart during exercise. Exercise gently puts the whole body under some pressure and therefore exposes any weaker areas.

In this study the investigators are hoping to find out what happens to the blood flow in the brain and in the heart in patients who have COPD when they exercise and in the resting state. This will be compared to people of a similar age with a similar smoking history but without COPD. This will be examined using state of the art magnetic resonance imaging (MRI) and will allow us to assess whether changes in structure and function are related to this altered blood flow.

Our hypothesis is that COPD will cause a larger change in blood flow during exercise compared to the healthy volunteers and that reduced cardiorespiratory fitness will be associated with increased age related structural within the brain.

研究概览

地位

未知

详细说明

The aim is to recruit 20 participants with COPD, who will be compared to 10 age and gender matched controls who also have a smoking history. The investigators aim for this number to complete the components of the study and therefore may have to over-recruit if some people drop out or are not eligible. The study elements are feasible, as the work extends a previous research study in healthy volunteers.

This research trial will consist of a medical screening visit and three investigation study visits spaced ideally one week apart. The investigation visits will begin within 6 (ideally within 4) weeks of the medical screening visit. The total duration of the study and screening visits should be 12 weeks maximum for each participant.

Screening visit:

If the participant expresses an interest in the clinical trial and wants to take part they will be invited (at a convenient time for them) to attend a medical screening visit located at the Nottingham City hospital. Here the investigator will discuss the research trial and answer any questions or concerns they might have regarding the research trial. The participant, if willing, will then be required to sign a consent form so that the screening procedures can begin, which include:

  • Blood sample: Approximately a 20ml sample (4 teaspoons) taken from their arm, for further investigation including full blood count (FBC), brain natriuretic peptide (BNP) and kidney function.
  • Questionnaires: 5 different questionnaires that ask about symptoms and how they affect daily life, a physical activity questionnaire, quality of life questionnaire and a MRI safety questionnaire.
  • Spirometry: A simple blowing test to assess the participants' breathing which is performed three times.
  • 12 lead ECG.
  • a hand grip dynamometer to assess muscle strength
  • timed up and go test: a test used to measure gait speed, where participants are asked to get up from a chair and walking to 3 meters and back, whilst being timed.
  • to wear a step counter (Sensewear armband) for a week during waking hours to record steps.

Provided the ECG, step count (<10,000 steps) and other screening elements are ok, the participant will proceed to Study visit 1.

Strength and exercise test protocol:

The participant will be required to abstain from strenuous exercise for the 48 hours prior to the visit and also from alcohol and caffeine for 24 hours prior. Upon arrival they will perform a knee extension exercise so we can establish the muscle strength in the legs, specifically 3 maximal knee extensions with a 30 second rest in between. We will also measure fatigue by dong 20 extensions after a short break.

After a break they will then undergo an exercise test using an MRI compatible stepper device (Ergospect Cardiostepper) whilst in a supine position. This has been adapted to be similar to how they will exercise in the MRI scanner. Volunteers will start off stepping at a frequency of 65-70 steps a minute at the minimum workload and every 3 minutes get gradually a little harder until exhaustion is reached. Heart rate at rest and in response to exercise will be measured using a heart monitor. Participants will be given the option to have their expired gases also measured during exercise using a face mask, though this is not necessary if not tolerated. In the final minute of each workload we will take a finger prick test to measure the gases in the patients blood. A 3 lead ECG and oxygen saturation probe will be attached during exercise as safety measures and the protocol will be halted if oxygen saturation falls below 80% or if any relevant rhythm abnormalities are seen on the ECG trace.

The second study visit will be used to confirm the exercise and strength parameters measured in the first study visit.

MRI protocol:

A series of scans of the brain and heart will be taken at rest and then whilst stepping on the stepper machine within the MRI. The exercise will be at a steady state low level intensity determined by calculating the workload at which a fraction of maximum heart rate was achieved during first 2 study visits.

The MRI scan itself will take about ¾ hour but upto 2 hours is allowed for preparation and introducing the scan to the participant. The scanner is quite noisy and so the participant will wear ear defenders during the scan. Because the scanner is built around a large magnet, the participant will be instructed to remove all metal from their body, including jewellery. There is no radiation involved.

研究类型

观察性的

注册 (预期的)

30

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Nottinghamshire
      • Nottingham、Nottinghamshire、英国、NG5 1PB
        • 招聘中
        • NIHR Nottingham BRC Respiratory Theme, University of Nottingham and NUH Trust
        • 接触:

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

60年 至 75年 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

取样方法

概率样本

研究人群

We are recruiting participants within the Nottinghamshire region. Specifically for patients with COPD, we are targeting outpatient respiratory clinics at the Nottingham University Hospitals Trust, inpatient admissions due to COPD exacerbation at the Nottingham City Hospital, pulmonary rehabilitation groups and respiratory focus groups within Nottingham and patients on the Nottingham Respiratory Research Unit database.

描述

Inclusion Criteria:

  • Patients aged 65-75 years old,
  • >10 pack years smoking,
  • FEV1/FVC <0.7 and FEV1<60% predicted (for COPD participants only)
  • Sedentary lifestyle (<10,000 steps per day)
  • Able to give informed consent
  • Able to read, understand and communicate coherently in English

Exclusion Criteria:

  • Doctor diagnosis of ischaemic heart disease or heart failure
  • Doctor diagnosis of dementia or Alzheimers disease
  • History of previous cerebrovascular disease (stroke or TIA) or malignancy
  • Pregnancy or childbearing in the last 6 months
  • Maintenance oral corticosteroids in the past 6 months
  • Requirement for oral corticosteroids or antibiotics in the past 6 weeks
  • Active arthritis or other muscular condition limiting exercise
  • Surgical intervention in the last 12 weeks
  • Long term oxygen therapy requirement
  • Other formal current respiratory diagnosis
  • Thyroid disease
  • Diabetes Mellitus
  • Neurological or cognitive impairment
  • Significant physical disability
  • Any other conditions in addition to the above that the investigators consider may affect study measurements or safety
  • Inability to understand verbal and/or written explanation of the study requirements

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 观测模型:病例对照
  • 时间观点:横截面

队列和干预

团体/队列
Case
Participants with a pack year history of more than 10 pack years, diagnosed with COPD who have FEV1/FVC ratio of less than 0.7 AND FEV1 predicted value less than or equal to 60%.
Control
Participants without a diagnosis of COPD who have a smoking history of more than 10 pack years

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Resting white and grey matter structural integrity
大体时间:up to 12 weeks
Grey and white matter volume (mm3) using the MRI MPRAGE sequences will be measured at rest
up to 12 weeks
Cardiac structural integrity
大体时间:up to 12 weeks
Cardiac output (L/min) will be measured using the MRI sequence (Short axis Cine) at rest.
up to 12 weeks
Cardiac structural integrity
大体时间:up to 12 weeks
Cardiac fibrosis (%) will be measured using the MRI MOLLI T1 sequence at rest.
up to 12 weeks
Cardiac structural integrity
大体时间:up to 12 weeks
Myocardial strain (%) will be measured using the MRI cardiac tagging sequence at rest.
up to 12 weeks
Whole body fat and muscle quantification
大体时间:up to 12 weeks
Whole body fat and muscle quantification (%) will be measured using the MRI whole body mdixon sequence at rest.
up to 12 weeks
Aortic flow
大体时间:up to 12 weeks
Aortic flow (ml/min) will be measured during rest, low level steady-state exercise and following cessation of exercise and compared between COPD and age and gender matched controls
up to 12 weeks
Cerebral blood flow
大体时间:up to 12 weeks
Cerebral blood flow (ml/min) will be measured during rest, low level steady-state exercise and following cessation of exercise and compared between COPD and age and gender matched controls
up to 12 weeks
Cerebral perfusion
大体时间:up to 12 weeks
Cerebral artery perfusion (ml/100g/min) will be measured during rest, low level steady-state exercise and following cessation of exercise and compared between COPD and age and gender matched controls
up to 12 weeks
Oxygen extraction fraction
大体时间:up to 12 weeks
Oxygen extraction fraction (%) will be derived from the difference between arterial and venous cerebral oxygenation measured via TRUST MRI scan sequence during rest, low level steady-state exercise and following cessation of exercise and compared between COPD and age and gender matched controls
up to 12 weeks

次要结果测量

结果测量
措施说明
大体时间
Muscle isometric strength (MVC)
大体时间:up to 6 weeks
Isometric muscle torque of the quadriceps (Nm) assessed using the cybex dynamometer
up to 6 weeks
Muscle isokinetic fatigue
大体时间:up to 6 weeks
Fatiguability test of the quadriceps (Nm) assessed using the cybex dynamometer
up to 6 weeks
Quality of life (SGRQ)
大体时间:1 week
Assessed using the St Georges Respiratory Questionnaire. min value: 0, max value: 84, higher score means worse outcome
1 week
Physical activity level (IPAQ Physical activity questionnaire)
大体时间:1 week
Assessed using the International Physical activity questionnaire. min value: 0, max value: 66000, higher score means better outcome
1 week
Montreal Cognitive Assessment (MoCA) cognition level
大体时间:1 week
Assessed using the Montreal cognitive assessment questionnaire. min value: 0, max value: 30, higher score means better outcome
1 week
Hospital anxiety and depression scale (HADS)
大体时间:1 week
min value: 0, max value: 21, higher score means worse outcome
1 week
Hand grip strength
大体时间:1 week
Composite of hand grip strength (Kg), measured by a hand held dynamometer,
1 week
Timed up and go test
大体时间:1 week
Timed up and go test (seconds) will be measured to assess degree of frailty.
1 week
Serum markers of inflammation for research purposes (likely to include IL-1, IL-6, and TNFα)
大体时间:1 week
Blood test
1 week
Heart rate response to exercise
大体时间:up to 6 weeks
Heart rate response (Beats per minute) will be measured at rest and during incremental exercise to assess cardio-respiratory fitness.
up to 6 weeks

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Charlotte Bolton、NIHR Nottingham Biomedical Research Centre Respiratory theme, University of Nottingham

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2019年1月3日

初级完成 (预期的)

2020年9月30日

研究完成 (预期的)

2020年9月30日

研究注册日期

首次提交

2019年10月17日

首先提交符合 QC 标准的

2019年10月22日

首次发布 (实际的)

2019年10月24日

研究记录更新

最后更新发布 (实际的)

2019年10月30日

上次提交的符合 QC 标准的更新

2019年10月28日

最后验证

2019年10月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

未定

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅